Welcome to our dedicated page for Walgreen Boots news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreen Boots stock.
Walgreens Boots Alliance, Inc. became a privately owned company after Sycamore Partners completed its acquisition of WBA in August 2025. News about the former public issuer centers on the transition of Walgreens and related businesses under private ownership, including Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD.
Recurring company updates also cover Walgreens' U.S. retail pharmacy and health-services operations, specialty pharmacy limited-distribution drug relationships, and capital actions tied to WBA and Walgreen Co. senior notes, including tender offers and consent solicitations.
Walgreens Boots Alliance (WBA) and VillageMD have announced the opening of three Village Medical clinics in Orlando, with plans for seven additional locations by year-end. This initiative aims to enhance patient access to coordinated pharmacy and primary care services, addressing the health needs of over 13 million Floridians with chronic conditions. The project will create approximately 400 jobs, including 200 high-paying STEM positions. The clinics will offer diverse insurance options and telehealth services, promoting improved health outcomes for patients.
Walgreens has administered over 29 million COVID-19 vaccinations across the U.S., witnessing a more than 30% increase in demand in key areas. The rise in cases, particularly due to the Delta variant, has also led to a doubling of testing volumes. As a safety measure, Walgreens has reinstated face cover requirements for all employees and mandated that U.S. support office team members be fully vaccinated by September 30. The company remains committed to health and wellness amid the ongoing pandemic.
Lemonaid Health has expanded its services into the United Kingdom, partnering with Boots UK, the leading pharmacy retailer. This marks Lemonaid's first international venture after seven years of operation in the U.S., providing online doctor visits and medicine delivery. The partnership allows Boots to offer its customers quick access to prescription-only medicines via online consultations. Services start at £15, and patients can also earn Boots Advantage Card points. The collaboration is expected to enhance patient care and accessibility in the U.K.
Lemonaid Health has announced its expansion into the United Kingdom, partnering with Boots UK, the largest pharmacy-led health and beauty retailer. This launch marks Lemonaid's first international venture following its success in the U.S. The service offers quick online consultations for prescription-only medication, with prices starting at £15. Patients can access their prescriptions via Boots pharmacies or home delivery. The partnership aims to enhance healthcare accessibility and improve patient outcomes through innovative telemedicine services.
Huggies and Walgreens have launched their fifth consecutive initiative to combat diaper need in America, with a goal of donating up to 1 million diapers through August 31, 2021. Customers can contribute by purchasing Huggies diapers at Walgreens, triggering a donation of a day's worth of diapers for each pack sold. Additionally, the #HuggiesStrollerSelfie Challenge encourages social media participation, with each selfie shared resulting in a $1 donation, up to $5,000. This effort aims to support families in need and raise awareness about diaper need, impacting one in three American families.
Walgreens Boots Alliance (Nasdaq: WBA) and VillageMD announced plans to open new Village Medical at Walgreens locations in Indiana, targeting communities including Merrillville, Griffith, Portage, and South Bend. The initiative aims to fulfill a commitment to open at least 600 locations across over 30 U.S. markets within four years, part of a $1 billion investment effort launched in January 2021. This partnership seeks to enhance healthcare access through a coordinated care model involving primary care physicians and Walgreens pharmacy services.
Walgreens Boots Alliance (Nasdaq: WBA) announced a quarterly dividend of 47.75 cents per share, reflecting a 2.1% increase. This dividend will be payable on September 10, 2021 to stockholders of record as of August 20, 2021, raising the annual rate from $1.87 to $1.91 per share. The company has maintained dividend payments for 355 consecutive quarters and increased dividends for 46 consecutive years, showcasing consistent financial stability.
Walgreens Boots Alliance (Nasdaq: WBA) and VillageMD will open 29 new Village Medical at Walgreens practices in Houston, Austin, and El Paso this year, aiming for at least 600 locations in over 30 U.S. markets within four years. This initiative is part of a $1 billion investment to enhance healthcare access through integrated services. The expansion targets over 825,000 patients aged 65+ in Texas, emphasizing the need for quality care. The collaborative model allows patients to benefit from coordinated pharmacy and primary care services, addressing chronic health issues effectively.
Walgreens has expanded its same day prescription delivery service to nearly all store locations, making it available seven days a week. This initiative aims to enhance customer convenience, allowing patients to manage prescriptions from home and receive medications within hours. Customers can enroll by texting 'Join Rx' to 21525. Delivery fees vary by location, and the service is not available in California. This enhancement follows Walgreens’ previous launch of same day delivery for over 24,000 retail products, reinforcing their commitment to a seamless omnichannel experience.
Walgreens Boots Alliance (WBA) reported Q3 FY2021 financial results with sales from continuing operations rising 12.1% to $34.0 billion. Operating income improved to $1.1 billion versus a loss of $1.7 billion a year ago, largely due to prior impairment charges. Adjusted net earnings soared 79.5% to $1.3 billion. WBA's EPS reached $1.38 compared to a loss of $1.95 last year. The company raised its guidance to approximately 10% growth in constant currency adjusted EPS for FY2021, reflecting strong performance in both domestic and international segments.